Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers develop a nonhuman primate model of Parkinson's disease

Nov. 24, 2021

Sanyou presents SYZJ-001 bispecific antibody drug against COVID-19

Nov. 23, 2021

Guard reports preclinical data on ROSgard in animal models of sepsis

Nov. 23, 2021

KAND-145 + cisplatin reduces tumor size in disease model of chemotherapy-resistant ovarian cancer

Nov. 23, 2021

Erythrocyte miR-210 as target for prevention of endothelial dysfunction in type 2 diabetes

Nov. 23, 2021

Bristol Myers Squibb adds structurally diverse compounds to BET inhibitor candidates

Nov. 23, 2021

PTSD model developed in Jeju minipig

Nov. 23, 2021

Novel mouse model of focal limbic seizures with impaired behavior

Nov. 23, 2021

New kappa-opioid receptor agonists discovered at Medshine Discovery

Nov. 23, 2021

Jiangsu Hengrui Medicine and collaborators patent inositol derivatives

Nov. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...